Literature DB >> 35274839

Basilar Artery Dissection in Myotonic Dystrophy Type 1.

Chan-Hyuk Lee1, Seung-Ho Jeon1, Byoung-Soo Shin1,2, Hyun Goo Kang1,3.   

Abstract

Entities:  

Year:  2022        PMID: 35274839      PMCID: PMC8926772          DOI: 10.3988/jcn.2022.18.2.227

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


× No keyword cloud information.
Dear Editor, Myotonic dystrophy type 1 (DM1) is caused by a genetic malfunction involving the overexpression of the CTG sequence in DMPK. This affects the skeletal, cardiac, and smooth muscles, presenting with abnormalities in several body areas. In particular, cardiac fibrosis caused by invasion into cardiac muscle is associated with a high incidence of atrial fibrillation in patients with DM1.1 Atrial fibrillation has been reported as a major causal factor of stroke in DM1.2 Although previous studies have shown that DM1 is associated with an abnormality of the vascular smooth muscle,3 there has been no report of DM1 being related to a compromise of the macrovascular system, which includes arterial dissection. Dissection of the basilar artery (BA) is a very rare disease with an annual incidence of 1/400,000. We report the case of a patient with DM1 who was diagnosed with an acute cerebral infarction due to BA dissection without trauma. Artery dissection could be another etiology of ischemic stroke in patients with myotonic dystrophy. A 58-year-old female visited our clinic due to a gait disturbance, which had worsened 7 days before her visit. She was diagnosed with myotonic dystrophy in her 20s. Her older sister had also been diagnosed with DM1 in her 20s. A neurological examination revealed sensory deficits following light touches in the left facial region and the upper and lower extremities. Moreover, a cerebellar function test revealed left-limb dysmetria and a left-sided falling tendency during gait (National Institutes of Health Stroke Scale score of 5 and modified Rankin Scale score of 3). Percussion myotonia was observed in the abductor pollicis brevis. The findings of routine laboratory tests including of thyroid function were normal. PCR-Southern analysis with a biotin-(CTG) 10 probe revealed that DMPK (CTG) was amplified with over 550 repeats. The characteristic myotonic discharge was observed in the overall muscles. Electrocardiography revealed atrial fibrillation, but no conduction defect or tachycardia was present. Acute infarction of the right pons was confirmed in brain diffusion-weighted magnetic resonance angiography (MRA) (Fig. 1A). Dissection was suspected in the middle portion of the BA (Fig. 1B, C). Transfemoral cerebral angiography was performed to confirm dissection, which revealed flame-like tapering with long-segment stenosis at the same site (Fig. 1D). She was administered 5 mg of apixaban twice daily and 40 mg of atorvastatin once daily, and was discharged after her limb ataxia and gait disturbance improved.
Fig. 1

A case of basilar artery (BA) dissection with acute right lateral pontine infarction. A: Brain noncontrast diffusion-weighted magnetic resonance angiography (MRA) image showing acute infarction involving the right lateral pons (arrow). B: A curved planar reformatted image generated using computed-tomography angiography shows tapered stenosis of the midbasilar artery with an intimal flap. C: Axial 2D time-of-flight MRA image in this patient demonstrates the double lumen with an intimal flap (arrowhead) around the BA.9 D: Conventional cerebral angiography image of the BA shows flame-like tapering of the proximal vessel with long-segment high-grade stenosis (arrowhead).

DM1 continuously weakens and depletes the muscles in the face, neck, and extremities, and it is characterized by myotonia when the invaded muscle is percussed.4 The severity of DM1 may vary in an individual patient. The adult-onset type is the most common, and its symptoms become distinct from the age of 40 years. DM1 is caused by mutations in DMPK located on chromosome 19q13.3. DM1 presents with abnormalities in several areas of the body, including the musculoskeletal, nervous, circulatory, and endocrine systems, and the gastrointestinal (GI) tract. DM1 presents with mainly musculoskeletal clinical symptoms. However, it also often presents with symptoms associated with the smooth muscle, including vomiting, constipation, diarrhea, and dysphagia resulting from the invasion of the smooth muscle of the GI tract, which can induce chronic intestinal pseudo-obstruction in adults. These GI symptoms can be the initial clinical manifestations of DM1, which may be followed by musculoskeletal symptoms. Histologically, it has been reported that the muscular layer of the small intestine in DM1 patients is segmented and damaged, similar to the effects on skeletal muscle. This suggests that the pathological mechanisms of DM1 are similar regardless of the muscle type.5 It has frequently been reported that DM1 involves the invasion of blood vessels.1 which may be related to dysfunction of the smooth muscle in the vascular walls. Itoh et al.6 applied a dipyridamole thallium-201 myocardial perfusion test to DM1 patients to confirm the presence of perfusion defects in the cardiac septum. Those authors considered that microvascular dysfunction in the heart could have damaged the myocardium. Myocardium damage in patients with DM1 can cause diverse types of cardiac dysfunction, including rhythm abnormality and sudden cardiac death.7 Moreover, the reported incidence of atrial fibrillation in patients with DM1 has been up to 30%, and this is the main cause of ischemic stroke.8 Yoshida et al.2 reported that 9 out of 71 patients with DM1 had ischemic stroke. Those authors also found that the atrial fibrillation rate was significantly higher in the ischemic stroke group than in the asymptomatic group. A causal analysis revealed that cardioembolism was the most common factor (six of out nine patients). Blood vessels structurally comprise the intima, media, and adventitia, with the media being the thickest layer, and consisting mainly of smooth muscle and elastic fibers. Therefore, DM1 may involve vascular damage, such as dissection, even in the presence of minor trauma caused by structural instability of the smooth muscle of the vascular media. The present subject was a DM1 patient without any specific history of trauma. It was suspected that intracranial artery dissection occurred incidentally because of the weakened smooth muscle in the intracranial artery as a result of DM1. There were no other intracranial atherosclerotic features other than findings suggesting BA dissection, even in brain MRA. It appears that this case is the first patient with DM1 who developed an ischemic stroke due to artery dissection rather than cardioembolism. The present findings suggest that complications due to structural instability resulting in artery dissection in DM1 can occur. Further extensive studies are needed to clearly explain the underlying mechanisms.
  8 in total

1.  The Frequency and Risk Factors for Ischemic Stroke in Myotonic Dystrophy Type 1 Patients.

Authors:  Kosuke Yoshida; Yoko Aburakawa; Yasuhiro Suzuki; Kenji Kuroda; Takashi Kimura
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-01-03       Impact factor: 2.136

Review 2.  Prevalence of atrial fibrillation in myotonic dystrophy type 1: A systematic review.

Authors:  Vincenzo Russo; Andrea Antonio Papa; Michele Lioncino; Anna Rago; Francesco Di Fraia; Alberto Palladino; Luisa Politano; Paolo Golino; Gerardo Nigro
Journal:  Neuromuscul Disord       Date:  2021-01-09       Impact factor: 4.296

3.  Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy.

Authors:  W Pruzanski; A G Huvos
Journal:  Arch Pathol       Date:  1967-03

4.  Microvascular ischemia in patients with myotonic dystrophy.

Authors:  H Itoh; M Shimizu; Y Horita; H Ino; T Taguchi; K Kajinami; K Yagi; D Chujo; H Mabuchi
Journal:  Jpn Circ J       Date:  2000-09

Review 5.  Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection.

Authors:  Stéphanie Debette; Annette Compter; Marc-Antoine Labeyrie; Maarten Uyttenboogaart; Tina M Metso; Jennifer J Majersik; Barbara Goeggel-Simonetti; Stefan T Engelter; Alessandro Pezzini; Philippe Bijlenga; Andrew M Southerland; Olivier Naggara; Yannick Béjot; John W Cole; Anne Ducros; Giacomo Giacalone; Sabrina Schilling; Peggy Reiner; Hakan Sarikaya; Janna C Welleweerd; L Jaap Kappelle; Gert Jan de Borst; Leo H Bonati; Simon Jung; Vincent Thijs; Juan J Martin; Tobias Brandt; Caspar Grond-Ginsbach; Manja Kloss; Tohru Mizutani; Kazuo Minematsu; James F Meschia; Vitor M Pereira; Anna Bersano; Emmanuel Touzé; Philippe A Lyrer; Didier Leys; Hugues Chabriat; Hugh S Markus; Bradford B Worrall; Stéphane Chabrier; Ralph Baumgartner; Christian Stapf; Turgut Tatlisumak; Marcel Arnold; Marie-Germaine Bousser
Journal:  Lancet Neurol       Date:  2015-06       Impact factor: 44.182

6.  The Role of the Atrial Electromechanical Delay in Predicting Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients.

Authors:  Vincenzo Russo; Anna Rago; Carmine Ciardiello; Maria Giovanna Russo; Paolo Calabrò; Luisa Politano; Gerardo Nigro
Journal:  J Cardiovasc Electrophysiol       Date:  2015-10-13

7.  Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon.

Authors:  D Annane; P Merlet; H Radvanyi; B Mazoyer; B Eymard; M Fiorelli; C Junien; M Fardeau; Z Ounnoughene; P Gajdos; A Syrota; D Duboc
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

8.  Ventricular tachycardia in patients with type 1 myotonic dystrophy: a case series.

Authors:  Anish Nikhanj; Soori Sivakumaran; Bailey Miskew-Nichols; Zaeem A Siddiqi; Gavin Y Oudit
Journal:  Eur Heart J Case Rep       Date:  2019-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.